Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting
for Proposed Business Combination
Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed business
combination adjourned to Friday, December 3, 2021, at 7:00 a.m. Central Time
New York, NY November 24, 2021
Foresight Acquisition Corp. (NASDAQ: FORE) (Foresight) announced that its Special Meeting of Foresights stockholders (the Special Meeting) relating to the proposed business combination (the
Business Combination) with P3 Health Partners (P3) that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned
until 7:00 a.m. Central Time on December 3, 2021.
As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional
time to file a proxy supplement to the definitive proxy statement that was filed with the Securities and Exchange Commission (SEC) on October 28, 2021 (the Proxy Statement) and mailed to Foresights stockholders,
and to provide Foresights stockholders additional time to review and consider the information to be set forth in such proxy supplement. The proxy supplement will contain revised Unaudited Pro Forma Financial Statements reflecting changes
related to the previously disclosed determination that the Business Combination should be accounted for as a business combination using the acquisition method of accounting rather than as a reverse recapitalization as currently provided for in the
Unaudited Pro Forma Financial Statements contained in the Proxy Statement. As previously disclosed, these changes will have no impact on the historical financial statements of P3 or Foresight that were included in the Proxy Statement. Foresight
expects to file the proxy supplement on or about Monday, November 29, 2021.
No changes have been made to the record date, the location of the
meeting or the proposals to be voted on at the Special Meeting, which are presented in the Proxy Statement filed with the SEC on October 28, 2021. The re-convened meeting will be held virtually at
https://www.cstproxy.com/foresightacq/2021. Only the holders of Foresights common stock as of the close of business on October 8, 2021, the record date for the Special Meeting, are entitled to vote at the Special
Meeting.
If you have already submitted your proxy, you do not need to take any action unless you wish to change your vote. You retain the power to revoke
your proxy or change your vote at any time before it is voted at the Special Meeting on December 3, 2021. Only the most recent proxy vote will be counted and all others will be discarded regardless of the method of voting. If a broker or other
nominee holds your stock on your behalf, you must contact your broker, bank or other nominee to change your vote. As a result of the adjournment, Foresight stockholders will be able to continue to change their redemption election on or prior to 5:00
p.m. Eastern Time on Wednesday, December 1, 2021.
If the proposals at the Special Meeting are approved, Foresight anticipates that the Business
Combination will close as promptly as practicable after the Special Meeting, subject to the satisfaction or waiver (as applicable) of all other closing conditions.
About Foresight Acquisition Corp.
Foresight is a special
purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit
foresightacq.com.